Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway
Authors
Keywords
-
Journal
CELL BIOLOGY AND TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-07
DOI
10.1007/s10565-023-09833-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic lupus erythematosus
- (2023) Yoshiya Tanaka BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure
- (2023) Yao Zhang et al. Hepatology International
- Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
- (2023) Daniele Accapezzato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway
- (2023) Xin Ba et al. JOURNAL OF ETHNOPHARMACOLOGY
- Transcriptome profiling reveals transcriptional regulation of VISTA in T cell activation
- (2023) Dingyi Yuan et al. MOLECULAR IMMUNOLOGY
- Lupus Recipe inhibits cGVHD‐induced lupus nephritis in mice and promote renal LC3‐associated autophagy
- (2023) Ruihua Liu et al. Immunity Inflammation and Disease
- Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse
- (2023) Shuzo Sato et al. Lupus Science & Medicine
- Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
- (2022) Xiao-cui Chen et al. Lupus Science & Medicine
- Lupus nephritis: new progress in diagnosis and treatment
- (2022) Chen Yu et al. JOURNAL OF AUTOIMMUNITY
- An active small molecule modulator M351‐0056 targeting the novel immune‐checkpoint protein VISTA
- (2021) Xinlei Hu et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
- (2021) Negar Hosseinkhani et al. Frontiers in Immunology
- Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling
- (2021) Chun-Ling Liang et al. Frontiers in Immunology
- Abnormalities of the type I interferon signaling pathway in lupus autoimmunity
- (2021) Stefania Gallucci et al. CYTOKINE
- Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline
- (2020) Kalliopi Klavdianou et al. BIODRUGS
- Structural insight into T cell coinhibition by PD-1H (VISTA)
- (2020) Benjamin T. Slater et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance
- (2020) Mohamed A. ElTanbouly et al. SCIENCE
- Systemic Lupus Erythematosus
- (2020) Marianthi Kiriakidou et al. ANNALS OF INTERNAL MEDICINE
- Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
- (2020) Jiao Jiang et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
- (2020) Guillermo Ruiz-Irastorza et al. RHEUMATOLOGY
- Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
- (2020) Candice Mazewski et al. Frontiers in Immunology
- Immunological pathogenesis and treatment of systemic lupus erythematosus
- (2019) Lu Pan et al. World Journal of Pediatrics
- Shared and Distinct Functions of Type I and Type III Interferons
- (2019) Helen M. Lazear et al. IMMUNITY
- Genomic Identification of Low-Density Granulocytes and Analysis of Their Role in the Pathogenesis of Systemic Lupus Erythematosus
- (2019) Brian J. Kegerreis et al. JOURNAL OF IMMUNOLOGY
- The Innate Part of the Adaptive Immune System
- (2019) Sophie Hillion et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- New therapies for systemic lupus erythematosus — past imperfect, future tense
- (2019) Grainne Murphy et al. Nature Reviews Rheumatology
- Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review
- (2019) Dominik Samotij et al. Biomed Research International
- Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation
- (2019) Nishant Mehta et al. Cell Reports
- PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
- (2019) Xue Han et al. Science Translational Medicine
- Belimumab: A Review in Systemic Lupus Erythematosus
- (2018) Hannah A. Blair et al. DRUGS
- VISTA expressed in tumour cells regulates T cell function
- (2018) Kumuluzi Mulati et al. BRITISH JOURNAL OF CANCER
- Immunoregulatory functions of VISTA
- (2017) Elizabeth C. Nowak et al. IMMUNOLOGICAL REVIEWS
- Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice
- (2017) PA Sergent et al. LUPUS
- VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis
- (2017) Sabrina Ceeraz et al. Arthritis & Rheumatology
- Noncanonical NF-κB Signaling in Health and Disease
- (2016) Gökhan Cildir et al. TRENDS IN MOLECULAR MEDICINE
- Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity
- (2014) L. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More